Kimberly H. Allison
机构：Cancer Institute (WIA), Stanford Medicine, Stanford Cancer Institute, Stanford University · ORCID：0000-0002-1776-0503
发表论文 195 篇 · 总被引 33581 次 · h-index 64
代表论文
- Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology (2022 · Journal of the National Comprehensive Cancer Network · 被引 981)
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update (2023 · Journal of Clinical Oncology · 被引 680)
- Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology (2024 · Journal of the National Comprehensive Cancer Network · 被引 655)
- NCCN Guidelines® Insights: Breast Cancer, Version 4.2023 (2023 · Journal of the National Comprehensive Cancer Network · 被引 461)
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer (2023 · Archives of Pathology & Laboratory Medicine · 被引 294)
- The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group (2021 · npj Breast Cancer · 被引 288)